UB Paderborn / Katalog / Suche / in CDI

1 – 25 von 159

Sortiert nach

Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells

PloS one, 2011-01, Vol.6 (1), p.e16013-e16013

2011

Volltextzugriff (PDF)

BCR-ABL1 compound mutations in tyrosine kinase inhibitor–resistant CML: frequency and clonal relationships

Blood, 2013-01, Vol.121 (3), p.489-498

2013

Volltextzugriff (PDF)

T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides

Journal of the American Academy of Dermatology, 2015-08, Vol.73 (2), p.228-236.e2

2015

Volltextzugriff (PDF)

Coexisting and cooperating mutations in NPM1 -mutated acute myeloid leukemia

Leukemia research, 2017-05, Vol.56, p.7-12

2017

Volltextzugriff (PDF)

Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia

Modern pathology, 2012-06, Vol.25 (6), p.795-804

2012

Volltextzugriff (PDF)

Detection of FLT3 Internal Tandem Duplication in Targeted, Short-Read-Length, Next-Generation Sequencing Data

The Journal of molecular diagnostics : JMD, 2013, Vol.15 (1), p.81-93

2013

Volltextzugriff (PDF)

Nicotinic receptor alpha7 expression identifies a novel hematopoietic progenitor lineage

PloS one, 2013-03, Vol.8 (3), p.e57481

2013

Volltextzugriff (PDF)

Induction of granzyme B expression in T-cell receptor/CD28-stimulated human regulatory T cells is suppressed by inhibitors of the PI3K-mTOR pathway

BMC immunology, 2009-11, Vol.10 (1), p.59-59

2009

Volltextzugriff (PDF)

Detection and Quantification of Acute Myeloid Leukemia-Associated Fusion Transcripts

Methods in molecular biology (Clifton, N.J.), 2017, Vol.1633, p.151

2017

Volltextzugriff (PDF)

Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified

Modern pathology, 2016-08, Vol.29 (8), p.854-864

2016

Volltextzugriff (PDF)

Genetic Testing in the Diagnosis and Biology of Myeloid Neoplasms : 2017 Society for Hematopathology/European Association for Haematopathology Workshop Report

American journal of clinical pathology, 2019-09, Vol.152 (3), p.302-321

2019

Volltextzugriff (PDF)

Genetic Testing in the Diagnosis and Biology of Myeloid Neoplasms (Excluding Acute Leukemias)

American journal of clinical pathology, 2019-08, Vol.152 (3), p.302-321

2019

Volltextzugriff (PDF)

T-cell rosettes in nodular lymphocyte–predominant Hodgkin lymphoma

Blood, 2017-02, Vol.129 (6), p.802-802

2017

Volltextzugriff (PDF)

Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanisms

Leukemia, 2020-11, Vol.34 (11), p.2981-2991

2020

Volltextzugriff (PDF)

Concurrent detection of targeted copy number variants and mutations using a myeloid malignancy next generation sequencing panel allows comprehensive genetic analysis using a single testing strategy

British journal of haematology, 2016-04, Vol.173 (1), p.49-58

2016

Volltextzugriff (PDF)

Nuclear-Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis

Clinical cancer research, 2019-04, Vol.25 (7), p.2323-2335

2019

Volltextzugriff (PDF)

Molecular genetic biomarkers in myeloid malignancies

Archives of pathology & laboratory medicine (1976), 2015-05, Vol.139 (5), p.594-601

2015

Volltextzugriff (PDF)

Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia

Experimental hematology, 2019-08, Vol.76, p.38-48.e2

2019

Volltextzugriff (PDF)

Detection of BCR-ABL1 mutations that confer tyrosine kinase inhibitor resistance using massively parallel, next generation sequencing

Annals of hematology, 2016-01, Vol.95 (2), p.201-210

2016

Volltextzugriff (PDF)

Macrophage-Colony-Stimulating Factor-Induced Activation of Extracellular-Regulated Kinase Involves Phosphatidylinositol 3-Kinase and Reactive Oxygen Species in Human Monocytes

The Journal of immunology (1950), 2002-12, Vol.169 (11), p.6427-6434

2002

Volltextzugriff (PDF)

A comparison of deep sequencing of TCRG rearrangements vs traditional capillary electrophoresis for assessment of clonality in T-Cell lymphoproliferative disorders

American journal of clinical pathology, 2014-03, Vol.141 (3), p.348-359

2014

Volltextzugriff (PDF)

The Ratio of FOXP3+ Regulatory T Cells to Granzyme B+ Cytotoxic T/NK Cells Predicts Prognosis in Classical Hodgkin Lymphoma and Is Independent of bcl-2 and MAL Expression

American journal of clinical pathology, 2007-12, Vol.128 (6), p.958-965

2007

Volltextzugriff (PDF)

A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemia

Leukemia & lymphoma, 2016-10, Vol.57 (10), p.2441-2444

2016

Volltextzugriff (PDF)

Clinical significance of cyclin D1, fibroblast growth factor receptor 3, and p53 immunohistochemistry in plasma cell myeloma treated with a thalidomide-based regimen

Human pathology, 2009-03, Vol.40 (3), p.405-412

2009

Volltextzugriff (PDF)

1 – 25 von 159

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(148)
Mit Volltextzugriff
(144)

Publikationsform

1 weiteren anzeigen...

Weniger anzeigen...

Sprache

Englisch
(158)
Japanisch
(23)

Erscheinungsjahr

n.n

Thema

15 weitere anzeigen...

Weniger anzeigen...

Kollektion

15 weitere anzeigen...

Weniger anzeigen...

Menü

Weitere Dienste

Einstellungen

Ncf1 (p47phox) is essential for direct regulatory T cell mediated suppression of CD4+ effector T cells

BCR-ABL1 compound mutations in tyrosine kinase inhibitor–resistant CML: frequency and clonal relationships

T-cell clonality assessment by next-generation sequencing improves detection sensitivity in mycosis fungoides

Coexisting and cooperating mutations in NPM1 -mutated acute myeloid leukemia

Targeted next generation sequencing of clinically significant gene mutations and translocations in leukemia

Detection of FLT3 Internal Tandem Duplication in Targeted, Short-Read-Length, Next-Generation Sequencing Data

Nicotinic receptor alpha7 expression identifies a novel hematopoietic progenitor lineage

Combining the Allosteric Inhibitor Asciminib with Ponatinib Suppresses Emergence of and Restores Efficacy against Highly Resistant BCR-ABL1 Mutants

Induction of granzyme B expression in T-cell receptor/CD28-stimulated human regulatory T cells is suppressed by inhibitors of the PI3K-mTOR pathway

Detection and Quantification of Acute Myeloid Leukemia-Associated Fusion Transcripts

Targeted next-generation sequencing identifies a subset of idiopathic hypereosinophilic syndrome with features similar to chronic eosinophilic leukemia, not otherwise specified

Genetic Testing in the Diagnosis and Biology of Myeloid Neoplasms : 2017 Society for Hematopathology/European Association for Haematopathology Workshop Report

Genetic Testing in the Diagnosis and Biology of Myeloid Neoplasms (Excluding Acute Leukemias)

T-cell rosettes in nodular lymphocyte–predominant Hodgkin lymphoma

Dasatinib overcomes stroma-based resistance to the FLT3 inhibitor quizartinib using multiple mechanisms

Concurrent detection of targeted copy number variants and mutations using a myeloid malignancy next generation sequencing panel allows comprehensive genetic analysis using a single testing strategy

Nuclear-Cytoplasmic Transport Is a Therapeutic Target in Myelofibrosis

Molecular genetic biomarkers in myeloid malignancies

Transcription factor Oct1 protects against hematopoietic stress and promotes acute myeloid leukemia

Detection of BCR-ABL1 mutations that confer tyrosine kinase inhibitor resistance using massively parallel, next generation sequencing

Macrophage-Colony-Stimulating Factor-Induced Activation of Extracellular-Regulated Kinase Involves Phosphatidylinositol 3-Kinase and Reactive Oxygen Species in Human Monocytes

A comparison of deep sequencing of TCRG rearrangements vs traditional capillary electrophoresis for assessment of clonality in T-Cell lymphoproliferative disorders

The Ratio of FOXP3+ Regulatory T Cells to Granzyme B+ Cytotoxic T/NK Cells Predicts Prognosis in Classical Hodgkin Lymphoma and Is Independent of bcl-2 and MAL Expression

A phase II study of the efficacy, safety, and determinants of response to 5-azacitidine (Vidaza®) in patients with chronic myelomonocytic leukemia

Clinical significance of cyclin D1, fibroblast growth factor receptor 3, and p53 immunohistochemistry in plasma cell myeloma treated with a thalidomide-based regimen

Suchergebnisse filtern